The effect of antiretrovirals on Plasmodium falciparum liver stages

AIDS

Volumn 27, Issue 10, 2013, Pages 1674-1677

  Hobbs, Charlotte V ^a   De La Vega, Patricia ^b   Penzak, Scott R ^c   Van Vliet, Jillian ^a   Krzych, Urszula ^b   Sinnis, Photini ^d   Borkowsky, William ^e   Duffy, Patrick E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOPINAVIR; NEVIRAPINE; SAQUINAVIR;

ANTIMALARIAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LIVER; LOPINAVIR; MALARIA, FALCIPARUM; NEVIRAPINE; PLASMODIUM FALCIPARUM; REVERSE TRANSCRIPTASE INHIBITORS; SAQUINAVIR;

EID: 84879099702     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283621dd4     Document Type: Article

References (24)

1. Flateau C, Le Loup G, Pialoux G. Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis 2011; 11:541-556.
2. Nsanzabana C, Rosenthal PJ. In vitro activity against Plasmodium falciparum of antiretroviral drugs. Antimicrob Agents Chemother 2011.
3. Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, et al. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. N Engl J Med 2012; 367:2110-2118.
4. Ikilezi G, Achan J, Kakuru A, Ruel T, Charlebois E, Clark TD, et al. Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. Am J Trop Med Hyg 2013.
5. Hobbs CV, Voza T, Coppi A, Kirmse B, Marsh K, Borkowsky W, et al. HIV protease inhibitors inhibit the development of pre-erythrocytic-stage Plasmodium parasites. J Infect Dis 2009; 199:134-141.
6. Hobbs CV, Voza T, De La Vega P, Vanvliet J, Conteh S, Penzak SR, et al. HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim- sulfamethoxazole inhibit Plasmodium liver stages. J Infect Dis 2012; 206:1706-1714.
7. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach and antiretroviral therapy for HIV infection in infants and children: Towards Universal Access, Recommendations for a Public Health Approach. http://whqlibdoc.who.int/publications/2010/ 9789241599764-eng.pdf and http://whqlibdoc.who.int/publications/2010/ 9789241599801-eng.pdf. [Accessed 14 February 2013]
8. WHO. Antiretroviral therapy for HIV infection in infants and children: Towards Universal Access, Recommendations for a Public Health Approach. http://whqlibdoc.who.int/publications/2010/9789241599801-eng.pdf. [Accessed 14 February 2013]
9. Sinnis P, Coppi A. A long and winding road: the Plasmodium sporozoite's journey in the mammalian host. Parasitol Int 2007; 56:171-178.
10. aidsinfo.gov. AIDSinfo Drug Database, Nevirapine. http://aidsinfo.nih. gov/drugs/116/nevirapine/0/professional. [Accessed 14 February 2013]
11. aidsinfo.gov. AIDSinfo Drug Database, Lopinavir. http://aidsinfo.nih.gov/ drugs/316/lopinavir-ritonavir/0/professional. [Accessed 14 February 2013]
12. aidsinfo.gov. AIDSinfo Drug database, Saquinavir. http://aidsinfo.nih. gov/drugs/164/saquinavir/0/professional. [Accessed 14 February 2013]
13. Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, Coleman RE, et al. Establishment of a human hepatocyte line that supportsin vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg 2006; 74:708-715.
14. VanBuskirk KM, O'Neill MT, De La Vega P, Maier AG, Krzych U, Williams J, et al. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A 2009; 106:13004-13009.
15. Ozaki LS, Gwadz RW, Godson GN. Simple centrifugation method for rapid separation of sporozoites from mosquitoes. J Parasitol 1984; 70:831-833.
16. Tsuji M, Mattei D, Nussenzweig RS, Eichinger D, Zavala F. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res 1994; 80:16-21.
17. Andrews KT, Fairlie DP, Madala PK, Ray J, Wyatt DM, Hilton PM, et al. Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother 2006; 50:639-648.
18. Martins TM, Domingos A, Berry C, Wyatt DM. The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi. Acta Trop 2006; 97:212-218.
19. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother 2005; 49: 2983-2985.
20. Skinner-Adams TS, McCarthy JS, Gardiner DL, Hilton PM, Andrews KT. Antiretrovirals as antimalarial agents. J Infect Dis 2004; 190:1998-2000.
21. Peatey CL, Andrews KT, Eickel N, MacDonald T, Butterworth AS, Trenholme KR, et al. Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrob Agents Chemother 2010; 54:1334-1337.
22. Hobbs CV, Tanaka TQ, Muratova O, Van Vliet J, Borkowsky W, Williamson KC, et al. HIV Treatments have malaria gametocyte killing and transmission blocking activity. J Infect Dis 2013.
23. Parikh S, Liu J, Sijwali P, Gut J, Goldberg DE, Rosenthal PJ. Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin. Antimicrob Agents Chemother 2006; 50: 2207-2209.
24. Lim PL, Tan W, Latchoumycandane C, Mok WC, Khoo YM, Lee HS, et al. Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04. Toxicol In Vitro 2007; 21:1390-1401.